What's new

ARPANSA is seeking nominations for 3 members of the Radiation Health Committee (RHC). The Committee advises the CEO on a range of radiation protection matters. It helps draft national policies, codes and standards on radiation protection, to promote and enable consistent regulation in Australia.

The Australian Nuclear Science and Technology Organisation (ANSTO) has submitted a licence application to decommission a nuclear installation, known as the High Flux Australian Reactor (HIFAR), at Lucas Heights Science and Technology Centre in Lucas Heights, New South Wales.

ARPANSA has launched new eye monitor technology to help medical workers track photon and beta radiation doses to the lens of their eyes.

Study finds speaking to the public helps to address radiation risk perceptions.

ARPANSA is seeking nominations for 9 members of the Nuclear Safety Committee (NSC). The Committee advises the CEO on nuclear safety and the safety of controlled facilities.

The Japanese Government has announced the release of treated water from the decommissioned Fukushima Daiichi Nuclear Power Plant into the Pacific Ocean will commence today, 24 August 2023, weather conditions permitting.

Recent STEM graduates are encouraged to apply to the Australian Radiation Protection and Nuclear Safety Agency’s Graduate Program with applications closing 11 September 2023.

ARPANSA has updated Australia’s nuclear medicine diagnostic reference levels to support optimised use of radiation in medical diagnosis and treatment.

The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) and the Australasian College of Dermatologists have collaborated to update advice on cosmetic treatments using non-ionising radiation for consumers and treatment providers.

The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) is pleased to announce The Hon Assistant Minister Ged Kearney MP’s appointment of Dr Jane Canestra as incoming Chair of the Radiation Health and Safety Advisory Council (RHSAC).

The International Atomic Energy Agency (IAEA) has released a comprehensive report reviewing the plans of Tokyo Electric Power Co. (TEPCO) and the Japanese Government to release treated radioactive water from the Fukushima Daiichi Nuclear Power Plant.

ARPANSA Acting CEO Dr Rick Tinker has removed a licence condition from the Australian Nuclear Science and Technology Organisation (ANSTO) Health Products facility following satisfactory implementation of recommendations following a 2018 safety review.

Researchers from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) recently attended a workshop on techniques to measure radio waves in the 24 – 30 GHz range, frequencies which are now being used in the latest implementation of the 5G network.

ARPANSA’s Radiation Monitoring Networks (RMN) team has resumed scheduled visits to the Comprehensive Test-Ban Treaty (CTBT) radionuclide monitoring station on the remote Pacific nation of Kiribati. The station is part of an international network of more than 320 monitoring stations that aim to ensure no nuclear explosion goes undetected.

ARPANSA and Swinburne University’s systematic map of 334 papers was published in May 2023. While there is currently no substantiated evidence of harm, it highlights the need for more high-quality research into the effects of radio waves from high-frequency wireless technology such as 5G on plants and animals.

Australia’s Chief Metrologist Bruce Warrington visited the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) on Tuesday 9 May to assess and re-authorise our primary standards for ionising radiation dosimetry.

Scientists at the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) have published a paper that shows the average exposure to radio waves from wireless technology in Melbourne is more than 700 times below the safety limit.

The CEO of ARPANSA has given notice of her intention to make a decision regarding a facility licence application for ARPANSA’s Medical Radiation Services Branch.